Institutions / Foresite Capital Management IV, LLC

Foresite Capital Management IV, LLC

CIK 1704132 · Institutionalso an insider · as of Dec 31, 2025
Portfolio value
$229.71M
Positions
7
As of
Dec 31, 2025

Top holdings

Dec 31, 2025
CompanyClassValueShares% of portfolio
Pharvaris N.V.—$132.61M4,778,58157.7%
Cytokinetics Inc—$29.12M458,29512.7%
Lyell Immunopharma, Inc.LYELCommon Stock$24.64M800,39910.7%
Maze Therapeutics, Inc.—$21.65M522,6579.4%
Relay Therapeutics, Inc.—$8.46M1,000,0003.7%
Xenon Pharmaceuticals Inc.—$7.17M160,0003.1%
Alector, Inc.—$6.06M3,887,2002.6%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.

Insider transactions

Also files Forms 3 / 4 / 5
DateActionCompanyValueShares ΔPosition afterImpact
Feb 4, 2026BuyEIKN
Eikon Therapeutics, Inc.
Common Stock
$1000.0K+56K
+4.40%
1,318,983
2.44% of shares
high
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+409K
408,725
0.75% of shares
low
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+38K
+9.84%
425,852
0.79% of shares
low
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+922
+0.24%
387,719
0.72% of shares
low
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+38K
+10.85%
386,797
0.71% of shares
low
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+349K
348,942
0.64% of shares
low
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+459K
+57.03%
1,263,428
2.33% of shares
low
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+67K
+9.11%
804,573
1.49% of shares
low
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+2K
+0.22%
737,366
1.36% of shares
low
Feb 4, 2026OtherEIKN
Eikon Therapeutics, Inc.
Common Stock
$0+38K
+5.42%
735,740
1.36% of shares
low